The major histocompatibility complex (MHC) class II is involved both in thymocyte maturationand peptide presentation and might thus play a key role in the pathogenesis of paraneoplasticmyasthenia gravis (MG) in thymomas. The gene discussed is HLA-C; the disease is thymoma.